诚意药业23年报暨24年季报说明会

Company and Industry Summary Company Overview - The meeting was initiated by the company, highlighting the operational performance and data for 2023, indicating a focus on sharing detailed insights with investors [1] Key Points and Arguments - The company expressed gratitude towards investors for their attendance and emphasized the importance of in-depth communication and collaboration for future development [1] Other Important Content - The presence of the company's executive vice president and chief secretary, Ms. Ke Zhihui, was noted, suggesting a structured approach to the meeting and a commitment to transparency [1]